| Bioactivity | EPZ020411 hydrochloride is a selective inhibitor of PRMT6 with an IC50 of 10 nM, it has >10 folds selectivity for PRMT6 over PRMT1 and PRMT8. EPZ020411 hydrochloride can be used for the research of cancer[1][2]. |
| Invitro | EPZ020411 hydrochloride (0-20 μM; 24 h) decreases H3R2 methylation in A375 cells[1].EPZ020411 hydrochloride (20-40 μM; 6 h) reduces neomycin- and cisplatin-induced cell apoptosis and increases hair cell survival[2]. Western Blot Analysis[1] Cell Line: |
| Name | EPZ020411 hydrochloride |
| CAS | 2070015-25-5 |
| Formula | C25H39ClN4O3 |
| Molar Mass | 479.06 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (stored under nitrogen) |
EPZ020411 hydrochloride
CAS: 2070015-25-5 F: C25H39ClN4O3 W: 479.06
EPZ020411 hydrochloride is a selective inhibitor of PRMT6 with an IC50 of 10 nM, it has >10 folds selectivity for PRMT6
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.